# Detection of Significant Coronary Artery Disease by Promising Biomarker: A2A Adenosine Receptor (A2AR) Assays

> **NCT05091749** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 312 (estimated)

## Conditions studied

- Chronic Coronary Syndromes

## Interventions

- **BIOLOGICAL:** blood samples

## Key facts

- **NCT ID:** NCT05091749
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-11-09
- **Primary completion:** 2024-03-10
- **Final completion:** 2025-12-01
- **Target enrollment:** 312 (ESTIMATED)
- **Last updated:** 2025-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05091749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05091749, "Detection of Significant Coronary Artery Disease by Promising Biomarker: A2A Adenosine Receptor (A2AR) Assays". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05091749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*